News

AddToAny

Google+ Facebook Twitter Twitter

New barometer for inflammatory disease

A unique discovery about the nature of neutrophils may lead to new models for diagnosing and tracking inflammatory diseases such as cancer and osteoarthritis. 

p10-13-news-prostate-cancer-science-photo-library-f0236971.jpg

Neutrophils are a class of leukocyte immune cell in the “innate” immune system, which deals with acute infections. Billions of neutrophils are born in the bone’s marrow each day to protect the body and attack microbial invaders.

Michael Glogauer, one of the study authors, said: “The general consensus in the past was that there is one kind of neutrophil in circulation in healthy people.

“We found two distinct neutrophil states in blood, and these populations vary depending on the health of patient and if there are acute or chronic infections.”

The team discovered this unique subset of immune cells after developing a novel method of preserving and analysing neutrophils in blood.  

Image credit | Science Photo Library 

Related Articles

neutrophil cell trapping bacteria Image Credit | Science Photo Library-p2760184

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

Tuberculosis vaccine bacteria-Image Credit | Science Photo Library - b2201433

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

genetics mutations cancer - CREDIT - alamy-2jkftm9

The evolution of cancer

Charlie Swanton outlines the work in cancer research that led to him being awarded a 2024 Louis-Jeantet Prize for translational medicine.

A nurse takes the blood pressures of a woman as she waits with an infant at Ndirande Health Centre in Blantyre on February 21, 2018 - Image credit - Getty-922184246

Vaccine effective in preventing typhoid fever

A single dose of the typhoid conjugate vaccine Typbar TCV provides lasting efficacy in preventing typhoid fever in children aged nine months to 12 years old, according to a new study.

Top